MicroRNA在骨代谢中的研究进展

doi:10.3969/j.issn.1671-7171.2017.03.030

摘要
图/表
参考文献
相关文章 (15)

[1] Kular J, Tickner J, Chim SM,et al. An overview of the regulation of bone remodelling at the cellular level[J].Clin Biochem,2012,45(12): 863-873.
[2] Carthew RW Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs[J].Cell,2009,136(4): 642-655.
[3] Lee Y, Jeon K, Lee JT, et al. MicroRNA maturation: stepwise processing and subcellular localization[J].EMBO J,2002,21(17): 4663-4670.
[4] Day TF, Guo X, Garrett-Beal L, et al. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis[J].Dev Cell,2005,8(5): 739-750.
[5] Li CJ, Cheng P, Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation[J].J Clin Invest,2015,125(4): 1509-1522.
[6] Zaragosi LE, Wdziekonski B, Brigand KL, et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis[J].Genome Biol,2011,12(7): R64.
[7] Clark EA, Kalomoiris S, Nolta JA, et al. Concise review: MicroRNA function in multipotent mesenchymal stromal cells[J].Stem Cells,2014,32(5): 1074-1082.
[8] Baglio SR, Devescovi V, Granchi D, et al. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31[J].Gene,2013,527(1): 321-331.
[9] Kim YJ, Bae SW, Yu SS, et al. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue[J].J Bone Miner Res,2009,24(5): 816-825.
[10] Mizuno Y, Tokuzawa Y, Ninomiya Y, et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b[J].FEBS letters,2009,583(13): 2263-2268.
[11] Li H, Xie H, Liu W, et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans[J].J Clin Invest,2009,119(12): 3666-3677.
[12] Li Z, Hassan M Q, Jafferji M, et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation[J].J Biol Chem,2009,284(23): 15676-15684.
[13] Kapinas K, Kessler C, Ricks T, et al. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop[J].J Biol Chem,2010,285(33): 25221-25231.
[14] Teixeira CC, Liu Y, Thant L M, et al. Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis[J].J Biol Chem,2010,285(40): 31055-31065.
[15] Inose H, Ochi H, Kimura A, et al. A microRNA regulatory mechanism of osteoblast differentiation[J].Proc Natl Acad Sci U S A,2009,106(49): 20794-20799.
[16] Wang X, Guo B, Li Q, et al. miR-214 targets ATF4 to inhibit bone formation[J].Nat Med,2013,19(1): 93-100.
[17] Dong J, Cui X, Jiang Z, et al. MicroRNA-23a modulates tumor necrosis factor-alpha-induced osteoblasts apoptosis by directly targeting Fas[J].J Cell Biochem,2013,114(12): 2738-2745.
[18] An JH, Ohn JH, Song JA, et al. Changes of microRNA profile and microRNA-mRNA regulatory network in bones of ovariectomized mice[J].J Bone Miner Res,2014,29(3): 644-656.
[19] Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions[J].J Dent Res,2013,92(10): 860-867.
[20] Cheng P, Chen C, He HB, et al. miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B[J].J Bone Miner Res,2013,28(5): 1180-1190.
[21] Liu T, Qin AP, Liao B, et al. A novel microRNA regulates osteoclast differentiation via targeting protein inhibitor of activated STAT3 (PIAS3)[J].Bone,2014,67: 156-165.
[22] Sugatani T, Vacher J ,Hruska KA. A microRNA expression signature of osteoclastogenesis[J].Blood,2011,117(13): 3648-3657.
[23] Krzeszinski JY, Wei W, Huynh H, et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2[J].Nature,2014,512(7515): 431-435.
[24] Qu B, Xia X, Yan M, et al. miR-218 is involved in the negative regulation of osteoclastogenesis and bone resorption by partial suppression of p38MAPK-c-Fos-NFATc1 signaling: Potential role for osteopenic diseases[J].Exp Cell Res,2015,338(1): 89-96.
[25] Franceschetti T, Kessler CB, Lee SK, et al. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration[J].J Biol Chem,2013,288(46): 33347-33360.
[26] Dou C, Zhang C, Kang F, et al. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation[J].Biochim Biophys Acta,2014,1839(11): 1084-1096.
[27] Mizoguchi F, Murakami Y, Saito T, et al. miR-31 controls osteoclast formation and bone resorption by targeting RhoA[J].Arthritis Res Ther,2013,15(5): R102.
[28] Seeliger C, Karpinski K, Haug AT, et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures[J].J Bone Miner Res,2014,29(8): 1718-1728.
[29] Wiggins JF, Ruffino L, Kelnar K,et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34[J].Cancer Res,2010,70(14): 5923-5930.
[30] Kim KM,Lim SK. Role of miRNAs in bone and their potential as therapeutic targets[J].Curr Opin Pharmacol,2014,16: 133-141.